Popees Baby Care India Approves Strategic Share Swap Acquisition of PBCPL
Popees Baby Care India Limited's board, at its May 16, 2026 meeting, approved a strategic share swap acquisition of Popees Baby Care Products Limited (PBCPL) through a preferential issue of securities for non-cash consideration, with an indicative swap ratio of approximately 1.3:1. The Audit Committee has been authorised to finalise valuation reports, determine the final swap ratio, and approve the SSPA terms. Upon completion, promoter shareholding will not exceed 75% of post-issue paid-up equity share capital, with no change in control or management.

*this image is generated using AI for illustrative purposes only.
Popees Baby Care India Limited (formerly known as Hari Govind International Limited) has announced the outcome of its Board of Directors meeting held on Saturday, May 16, 2026. Pursuant to Regulations 30 and 30A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the board deliberated upon and approved a proposed strategic acquisition of Popees Baby Care Products Limited ("PBCPL") through a share swap arrangement. The meeting commenced at 06.30 p.m. and concluded at 07.20 p.m.
Strategic Acquisition via Share Swap Arrangement
The board considered and approved a proposed strategic acquisition and investment transaction involving PBCPL, referred to as the Target Company, through a preferential issue of securities for consideration other than cash. The transaction is subject to receipt of requisite statutory, regulatory, and shareholders' approvals. In connection with this, the board reviewed a draft Share Subscription and Share Purchase Agreement ("SSPA") proposed to be entered into amongst Popees Baby Care India Ltd. ("PBC India"), PBCPL, and the existing shareholders and investors of PBCPL. The board noted that certain promoter and promoter group members of the company are existing shareholders and promoters of PBCPL, an unlisted public company. The proposed transaction was characterised as a strategic business consolidation and restructuring involving the acquisition of securities of an unlisted entity through a share swap arrangement, to be undertaken based on independent valuation reports and fairness opinions, and in compliance with all applicable statutory and regulatory requirements.
The transaction contemplates the acquisition and subscription of shares and securities of the Target Company by PBC India, and the issuance and allotment of equity shares and/or other eligible securities of the company to the investors of PBCPL on a preferential basis, in accordance with the Companies Act, 2013, SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, SEBI Listing Regulations, and other applicable laws.
Indicative Share Swap Ratio and Key Transaction Parameters
The board discussed the valuation parameters, commercial terms, and indicative swap mechanism for the proposed transaction. The following table summarises the key details of the approved transaction:
| Parameter: | Details |
|---|---|
| Transaction Type: | Strategic Acquisition / Share Swap Arrangement |
| Target Company: | Popees Baby Care Products Ltd. (PBCPL) |
| Mode of Consideration: | Preferential issue of securities, other than cash |
| Indicative Swap Ratio: | Approximately 1.3:1 |
| Regulatory Framework: | Companies Act, 2013; SEBI ICDR Regulations, 2018; SEBI Listing Regulations |
| Meeting Date: | Saturday, May 16, 2026 |
| Signatory: | Shaju Thomas, Managing Director (DIN: 06412983) |
The indicative swap ratio of approximately 1.3:1 is subject to final valuation reports, fairness opinions, due diligence findings, final negotiated transaction documents, and applicable statutory and regulatory approvals. The final swap ratio shall be determined and approved by the Audit Committee of the company.
Audit Committee Authorization and Further Actions
The board authorised the Audit Committee to review and finalise valuation reports and fairness opinions from registered valuers and independent professionals, determine and approve the final share swap ratio, and negotiate, modify, finalise, and approve the detailed terms of the SSPA and all ancillary agreements. The Audit Committee has also been empowered to appoint advisors, valuers, consultants, legal counsel, and other intermediaries as required, and to undertake all necessary actions, filings, and compliances in relation to the proposed transaction. Additionally, the board authorised the management to undertake all acts and steps necessary for giving effect to the transaction, including seeking approvals from stock exchanges, shareholders, and other regulatory authorities wherever applicable.
Promoter Shareholding and Control
The board noted that upon completion of the proposed preferential issue and share swap transaction, the promoter and promoter group shareholding of the company shall remain within the limits prescribed under the Securities Contracts (Regulation) Rules, 1957, and shall not exceed 75% of the post-issue paid-up equity share capital. The board further confirmed that there shall be no change in the existing promoter and promoter group, and no change in control or management of the company pursuant to the proposed transaction. The transaction is intended to strengthen business synergies, strategic growth opportunities, and long-term value creation for stakeholders. Full disclosures as required under Regulation 30 of the SEBI Listing Regulations shall be submitted upon finalisation and execution of definitive agreements and completion of other material events related to the proposed transaction.
How might the consolidation of PBCPL into PBC India affect the combined entity's competitive positioning against established players in India's rapidly growing baby care market?
Given that promoter and promoter group members hold stakes in both companies, what governance safeguards will the Audit Committee implement to ensure the final swap ratio is fair to minority shareholders of PBC India?
What are the potential revenue and EBITDA synergies that could be unlocked post-merger, and over what timeline could investors realistically expect these synergies to materialize?

























